Source: Annual Congress 2005 - Advancements in diffuse parenchymal lung disease
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
H. Qun, S. Izumi, H. Miyazawa, B. Uchiyama, S. Tanaka, T. Ishida, Y. Nagai, T. Tanaka, S. Fukuyama, R. Tazawa, M. Kanazawa, K. Yoshimura, T. Tachibana, K. Kudoh, T. Nukiwa, K. Hagiwara (Moroyama, Japan). Identification of a chromosome location linked to pulmonary alveolar microlithiasis (PAM). Eur Respir J 2005; 26: Suppl. 49, 1813

Member's Comments

No comment yet.

Related content which might interest you: Pulmonary alveolar microlithiasis (PAM) Source: Eur Respir J 2001; 18: Suppl. 33, 220s Year: 2001 Eight novel variants in the SLC34A2 gene in pulmonary alveolar microlithiasis Source: Eur Respir J, 55 (2) 1900806; 10.1183/13993003.00806-2019 Year: 2020 New mutation associated to the pulmonary alveolar microlithiasis Source: Annual Congress 2010 - Rare diffuse lung diseases Year: 2010 Different mutations in the SLC34A2 gene are showed in Chinese patients of pulmonary alveolar microlithiasis Source: Annual Congress 2009 - Genetics of lung diseases Year: 2009 Characterization of the gene network driving the whole lung lavage (WLL) outcome in Pulmonary Alveolar Proteinosis (PAP). Source: International Congress 2018 – Progress in rare interstitial lung diseases Year: 2018 A gene network to predict the clinical response to whole lung lavage (WLL), in pulmonary alveolar proteinosis (PAP). Source: International Congress 2017 – Novel and old entities Year: 2017 Pulmonary alveolar proteinosis due to a novel mutation in CSF2RA Source: Annual Congress 2012 - Paediatric bronchology Year: 2012 Peculiarities of pulmonary alveolar proteinosis (PAP) due to exogenous factors Source: Virtual Congress 2020 – Occupational exposure as a cause of respiratory disease Year: 2020 Pulmonary alveolar microlithiasis Source: Eur Respir Rev, 29 (158) 200024; 10.1183/16000617.0024-2020 Year: 2020 Pulmonary alveolar microlithiasis Source: International Congress 2019 – Insights into paediatric bronchology Year: 2019 MUC1 gene polymorphisms are associated with serum KL-6 levels and pulmonary dysfunction in pulmonary alveolar proteinosis Source: Annual Congress 2013 –Diffuse parenchymal lung disease I Year: 2013 Association of pulmonary alveolar proteinosis and fibrosis: patient with GATA2 deficiency Source: Eur Respir J 2016; 48: 1510-1514 Year: 2016 The analysis of alveolar macrophage form in secondary pulmonary alveolar proteinosis complicated with myelodysplastic syndrome. Source: International Congress 2017 – Rare diseases Year: 2017 Pulmonary alveolar microlithiasis: case report Source: Eur Respir J 2004; 24: Suppl. 48, 670s Year: 2004 Pulmonary alveolar microlithiasis: a case report Source: Eur Respir J 2004; 24: Suppl. 48, 489s Year: 2004 Interstitial lung disease in a baby with a de novo mutation in the SFTPC gene Source: Eur Respir J 2004; 24: 30-39 Year: 2004 Pulmonary alveolar proteinosis (PAP) - clinical features and response to treatment by bronchofiberoscopic lobar lavage Source: Eur Respir J 2005; 26: Suppl. 49, 541s Year: 2005 Pulmonary alveolar microlithiasis: no longer in the stone age Source: ERJ Open Res, 6 (3) 00289-2020; 10.1183/23120541.00289-2020 Year: 2020 Comparative proteome analysis of lung tissue from patients with idiopathic pulmonary fibrosis (IPF) and non-specific interstitial pneumonia (NSIP) Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease Year: 2013 Lung cysts in pulmonary alveolar proteinosis. Source: International Congress 2018 – Pitfalls in the diagnosis and management of rare diffuse parenchymal lung diseases (DPLDs) Year: 2018